Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury

Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury

  • CN 103,396,993 A
  • Filed: 07/11/2003
  • Published: 11/20/2013
  • Est. Priority Date: 07/11/2002
  • Status: Active Grant
First Claim
Patent Images

1. as the differentiated cell population of the part of the system that produces neurogliocyte, wherein at least~

  • 80% of this differentiated cell population cell is oligodendroglia precursor, and described precursor has following feature;

    They are offsprings that the primate multipotency is done (pPS) cell;

    They adopt special antibody staining for the NG2 proteoglycan;

    AndThey are neurone marker NeuN feminine genders;

    And wherein this system also comprises the pPS clone that produces described noble cells.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×